Eli Lilly and Company (LLY)

Add to Watchlists Create an Alert
54.14 -0.60  -1.10%   NYSE May 24, 5:00PM BATS Real time Currency in USD

Eli Lilly and Company R&D Expense Quarterly:

1.348B for March 31, 2013
View Full Chart

Eli Lilly and Company R&D Expense Quarterly Chart

    Eli Lilly and Company Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 1.348B
    Dec. 31, 2012 1.463B
    Sept. 30, 2012 1.343B
    June 30, 2012 1.321B
    March 31, 2012 1.152B
    Dec. 31, 2011 1.355B
    Sept. 30, 2011 1.281B
    June 30, 2011 1.261B
    March 31, 2011 1.124B
    Dec. 31, 2010 1.438B
    Sept. 30, 2010 1.220B
    June 30, 2010 1.187B
    March 31, 2010 1.039B
    Dec. 31, 2009 1.217B
    Sept. 30, 2009 1.122B
    June 30, 2009 1.040B
    March 31, 2009 947.30M
    Dec. 31, 2008 1.059B
    Sept. 30, 2008 953.00M
    June 30, 2008 951.50M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    LLY R&D Expense Quarterly Benchmarks

    Companies
    Sanofi 1.480B
    Pfizer 1.80B
    Merck 1.907B

    LLY R&D Expense Quarterly Rankings

    Overall 99th percentile
    14 of 8009
    Sector 98th percentile
    7 of 687 in Healthcare
    Industry 87th percentile
    7 of 55 in Drug Manufacturers - Major

    LLY R&D Expense Quarterly Range, Past 5 Years

    Minimum 947.30M Mar 2009
    Maximum 1.463B Dec 2012
    Average 1.191B